TALDO1 promotes lipid metabolic reprogramming and immunosuppressive microenvironment remodelling in hepatocellular carcinoma
Clinical and Translational Medicine · 2026
DOI: 10.1002/ctm2.70771 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Medicine, 2026. Verfasst von Fenglin Lv und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery, The Second Qilu Hospital of Shandong University, Jinan, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Tumor Microenvironment, Lipid Metabolism. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Natural Science Foundation of Shandong Province, China University Industry-University-Research Innovation Fund.
Abstract (Originalsprache)
Background
Hepatocellular carcinoma (HCC) is characterized by pronounced metabolic reprogramming and is frequently accompanied by the development of an immunosuppressive microenvironment. However, the key molecular mediators linking tumour metabolic dysregulation to immune microenvironment remodelling remain insufficiently defined. This study aimed to identify critical metabolic genes in HCC and to investigate their roles in lipid metabolic reprogramming and immunosuppression.
Methods
A deep autoencoder was used to extract latent metabolic features from HCC and identify TALDO1 as a key candidate gene. The expression pattern and prognostic significance of TALDO1 were evaluated across multiple independent cohorts and further validated in clinical specimens. Multi‐omics analyses combined with experimental validation were then used to elucidate the role of TALDO1 in lipid metabolic reprogramming and its effects on immune microenvironment remodelling in HCC.
Results
TALDO1 was identified as a key metabolic gene associated with HCC progression and was consistently upregulated across multiple clinical cohorts. Mechanistically, TALDO1 promoted lipogenesis and lipid accumulation in HCC cells by suppressing AMPK activation and sustaining SREBP1 maturation. TALDO1 silencing also reduced the secretion of several fatty acids and lipid mediators. Multi‐omics analyses together with multiplex immunofluorescence validation showed that high TALDO1 expression was associated with an immunosuppressive microenvironment in HCC. Coculture experiments further demonstrated that TALDO1 silencing attenuated the ability of HCC cells to induce M2‐like macrophage polarization and promote phenotypes associated with T‐cell exhaustion. In vivo, TALDO1 loss was accompanied by reduced immunosuppressive cell infiltration, enhanced effector T‐cell activity, and impaired tumour growth. Consistently, TALDO1 silencing also markedly suppressed tumour growth in patient‐derived xenograft models.
Conclusions
TALDO1 promotes lipid metabolic reprogramming in HCC and participates in the formation of an immunosuppressive microenvironment. These findings suggest that TALDO1 may serve as a key molecule linking metabolic abnormalities to immune microenvironment remodelling and may have potential therapeutic significance. Key points TALDO1 promotes lipid metabolic reprogramming in HCC by regulating AMPK/SREBP1 signaling. TALDO1 is associated with the formation of an immunosuppressive tumour microenvironment. Multi‐omics analyses identified an association of TALDO1 with HCC progression and poor prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hepatobiliary Surgery, The Second Qilu Hospital of Shandong University, Jinan, China.
- Shandong Province Engineering Research Center for Multidisciplinary Research on Hepatobiliary and Pancreatic Malignant Tumors, Jinan, China.
- Department of Pathology, The Second Qilu Hospital of Shandong University, Jinan, Shandong, China.
- The Department of Cardiovascular Ultrasound, Central hospital affiliated to Shandong First Medical University, Jinan, China.
- Department of General Surgery, Qingdao Central Hospital, School of Clinical Medicine, University of Health and Rehabilitation Sciences, Qingdao, China.
- Department of Infectious Diseases and Hepatology, The Second Qilu Hospital of Shandong University, Jinan, China.
ORCID-Profile: Bin Jin
Förderung
- National Natural Science Foundation of China
- National Natural Science Foundation of Shandong Province
- China University Industry-University-Research Innovation Fund
- Internal Cultivation Fund of the Second Qilu Hospital of Shandong University
Zitieren
APA
Lv, F., Zhou, H., Yang, J., Xu, J., Bi, F., Zhou, Y., Zhang, H., Ye, Q., Gao, L., & Jin, B. (2026). TALDO1 promotes lipid metabolic reprogramming and immunosuppressive microenvironment remodelling in hepatocellular carcinoma. Clinical and Translational Medicine. https://doi.org/10.1002/ctm2.70771
Vancouver
Lv F, Zhou H, Yang J, Xu J, Bi F, Zhou Y, et al. TALDO1 promotes lipid metabolic reprogramming and immunosuppressive microenvironment remodelling in hepatocellular carcinoma. Clinical and Translational Medicine. 2026. doi:10.1002/ctm2.70771
BibTeX
@article{Lv2026,
author = {Lv, Fenglin and Zhou, Huaxin and Yang, Jingyan and Xu, Jianglei and Bi, Fanqing and Zhou, Yi and Zhang, Hao and Ye, Qian and Gao, Lin and Jin, Bin},
title = {TALDO1 promotes lipid metabolic reprogramming and immunosuppressive microenvironment remodelling in hepatocellular carcinoma},
journal = {Clinical and Translational Medicine},
year = {2026},
doi = {10.1002/ctm2.70771}
}
EUVIMED